Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Jul;17(4):413-21.
doi: 10.1177/1099800414565170. Epub 2015 Jan 9.

Neurogenetic and Neuroimaging Evidence for a Conceptual Model of Dopaminergic Contributions to Obesity

Affiliations
Review

Neurogenetic and Neuroimaging Evidence for a Conceptual Model of Dopaminergic Contributions to Obesity

Ansley Grimes Stanfill et al. Biol Res Nurs. 2015 Jul.

Abstract

As the incidence of obesity continues to rise, clinicians and researchers alike are seeking explanations for why some people become obese while others do not. While caloric intake and physical activity most certainly play a role, some individuals continue to gain weight despite careful attention to these factors. Increasing evidence suggests that genetics may play a role, with one potential explanation being genetic variability in genes within the neurotransmitter dopamine pathway. This variability can lead to a disordered experience with the rewarding properties of food. This review of literature examines the extant knowledge about the relationship between obesity and the dopaminergic reward pathways in the brain, with particularly strong evidence provided from neuroimaging and neurogenetic data. Pubmed, Google Scholar, and Cumulative Index to Nursing and Allied Health Literature searches were conducted with the search terms dopamine, obesity, weight gain, food addiction, brain regions relevant to the mesocortical and mesolimbic (reward) pathways, and relevant dopaminergic genes and receptors. These terms returned over 200 articles. Other than a few sentinel articles, articles were published between 1993 and 2013. These data suggest a conceptual model for obesity that emphasizes dopaminergic genetic contributions as well as more traditional risk factors for obesity, such as demographics (age, race, and gender), physical activity, diet, and medications. A greater understanding of variables contributing to weight gain and obesity is imperative for effective clinical treatment.

Keywords: BMI; dopamine; genetics; obesity.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1
Figure 1
A conceptual model of weight gain leading to obesity. The spokes dividing the factors leading to obesity are composed of broken lines to indicate the interaction among them, similar to the model proposed by Ziauddeen, Farooqi, and Fletcher (2012). We altered the categories from the original model to reflect the information we have presented in this review as well as additional clinical observations that we have made. Additionally, we represented the outside of the wheel with another broken boundary to represent the influence that as-yet-unidentified factors could have on the outcome of weight gain leading to obesity. Adapted by permission from Macmillan Publishers Ltd: Ziauddeen, H., Farooqi, I. S., & Fletcher, P. C. (2012). Obesity and the brain: How convincing is the addiction model? Nature Reviews Neuroscience, 13(4), 279–286. Copyright 2012.

Similar articles

Cited by

References

    1. Allison DB, Mentore JL, Heo M, Chandler LP, Cappelleri JC, Infante MC, Weiden PJ. Antipsychotic-induced weight gain: A comprehensive research synthesis. American Journal of Psychiatry. 1999;156:1686–1696. - PubMed
    1. Annerbrink K, Westberg L, Nilsson S, Rosmond R, Holm G, Eriksson E. Catechol O-methyltransferase val158-met polymorphism is associated with abdominal obesity and blood pressure in men. Metabolism: Clinical and Experimental. 2008;57:708–711. - PubMed
    1. Asghari V, Sanyal S, Buchwaldt S, Paterson A, Jovanovic V, Van Tol HH. Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. Journal of Neurochemistry. 1995;65:1157–1165. - PubMed
    1. Baik JH. Dopamine signaling in food addiction: Role of dopamine D2 receptors. BMB Reports. 2013;46:519–526. - PMC - PubMed
    1. Balciuniene J, Emilsson L, Oreland L, Pettersson U, Jazin E. Investigation of the functional effect of monoamine oxidase polymorphisms in human brain. Human Genetics. 2002;110:1–7. - PubMed

Publication types

Substances